Startups
Edit
COI Pharmaceuticals
http://www.coipharma.com/Last activity: 13.11.2019
Active - Reference to Avalon Bio Ventures
COI Pharma provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded.
COI Pharmaceuticals, (COI=Community of Innovation), was established to provide Avalon Ventures’ portfolio companies a fully-equipped R&D infrastructure and industry mentors prepared to leverage their expertise to help entrepreneurial scientists succeed. By eliminating the operational noise that can distract scientists from drug discovery, COI Pharma empowers life science inventors to focus on driving a big idea forward and going where the science and their instincts take them.
The COI approach is based on Avalon Ventures’ proven portfolio strategy for launching disruptive drug discovery, technology platform and healthcare IT companies in new market areas and providing ongoing support as they grow and increase in value. Avalon’s approach to early-stage venture investing is the convergence of a unique capital structure, real-time decision making, and the startup wisdom of our venture partners who are seasoned serial entrepreneurs.
COI Pharmaceuticals, (COI=Community of Innovation), was established to provide Avalon Ventures’ portfolio companies a fully-equipped R&D infrastructure and industry mentors prepared to leverage their expertise to help entrepreneurial scientists succeed. By eliminating the operational noise that can distract scientists from drug discovery, COI Pharma empowers life science inventors to focus on driving a big idea forward and going where the science and their instincts take them.
The COI approach is based on Avalon Ventures’ proven portfolio strategy for launching disruptive drug discovery, technology platform and healthcare IT companies in new market areas and providing ongoing support as they grow and increase in value. Avalon’s approach to early-stage venture investing is the convergence of a unique capital structure, real-time decision making, and the startup wisdom of our venture partners who are seasoned serial entrepreneurs.
Overview
Employees
11-50
Founded date
2013
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 11, 2019 | GlaxoSmithKline to Acquire Sitari | SAN DIEGO–(BUSINESS WIRE)–Avalon Ventures today announced that it entered into a definitive agreement with GlaxoSmithKline (GSK) for the acquisition of Sitari Pharmaceuticals by GSK. Sitari has been developing a novel treatment for celiac d... |
| Sep 28, 2016 | Avalon Ventures Leads $18M Series A for Fortis Therapeutics | Fortis Therapeutics, Inc., a new immuno-oncology biotech, today announced the close of an $18 million Series A financing. The investment was led by Avalon Ventures and was joined by Bregua Corporation, Lilly Asia Ventures, Osage University ... |
| Sep 28, 2016 | Osage Joins $18M Series A for Fortis Therapeutics | Fortis Therapeutics, Inc., a new immuno-oncology biotech, today announced the close of an $18 million Series A financing. The investment was led by Avalon Ventures and was joined by Bregua Corporation, Lilly Asia Ventures, Osage University ... |
| Nov 9, 2015 | Avalon Ventures and GSK Expand Collaboration; Invest $10M in Iron Horse Therapeutics | Avalon Ventures and GSK are expandind their collaboration to fund and launch early-stage life science companies in San Diego. The collaboration is now worth up to a potential additional $60m in combined funding and earn-outs per company. Un... |
Reviews 0
FAQ about COI Pharmaceuticals
When was COI Pharmaceuticals founded?
COI Pharmaceuticals was founded in 2013.
What has the press written about COI Pharmaceuticals?
Parsers VC has collected 5 articles mentioning COI Pharmaceuticals, among them “GlaxoSmithKline to Acquire Sitari” (Sep 11, 2019) and “Avalon Ventures Leads $18M Series A for Fortis Therapeutics” (Sep 28, 2016).
Is COI Pharmaceuticals still active?
Yes, COI Pharmaceuticals is active; its latest activity on Parsers VC dates from Nov 13, 2019.